ZNT2 AS A NOVEL THERAPEUTIC TARGET: ELIMINATING PROTECTION FROM ZINC ACCUMULATION IN BREAST CANCER

$108,924FY2009Department of the ArmyDOD

The Pennsylvania State University

Investigators

ZNT2 AS A NOVEL THERAPEUTIC TARGET: ELIMINATING PROTECTION FROM ZINC ACCUMULATION IN BREAST CANCER · GrantIndex